S'abonner

Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood - 30/01/14

Doi : 10.1016/j.jaci.2013.06.034 
Anna Lluis, PhD a, , Martin Depner, PhD a, , Beatrice Gaugler, PhD b, Philippe Saas, PhD b, Vera Isabel Casaca, MSc a, Diana Raedler a, Sven Michel, MSc c, Jorg Tost, PhD d, Jing Liu, MD a, e, Jon Genuneit, MD f, Petra Pfefferle, PhD g, Marjut Roponen, PhD h, Juliane Weber, MD a, Charlotte Braun-Fahrländer, MD i, j, Josef Riedler, MD k, Roger Lauener, MD l, Dominique Angèle Vuitton, PhD m, Jean-Charles Dalphin, MD, PhD m, Juha Pekkanen, MD n, o, Erika von Mutius, MD, MSc a, Bianca Schaub, MD a,
and the

Protection Against Allergy: Study in Rural Environments Study Group

A. Hyvärinen n, A. Karvonen n, M.R. Hirvonen n, P. Tiittanen n, S. Remes n, V. Kaulek b, M.L. Dalphin b, M. Ege M a, G. Büchele f, S. Bitter i, j, G. Loss i, j, C. Roduit l, R. Frei l, H. Renz g, M. Kabesch c, G. Doekes p
a LMU Munich, University Children's Hospital, Munich, Germany 
b University Hospital of Besançon and Plateforme de Biomonitoring, CIC-BT506, EFS Bourgogne Franche-Comté, INSERM UMR1098, University of Franche-Comté, Besançon, France 
c University Children's Hospital Eastern Bavaria (KUNO), Department of Pediatric Pneumology and Allergy, University of Regensburg, Regensburg, Germany 
f Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany 
g Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany 
i Swiss Tropical and Public Health Institute, Basel, Switzerland 
j University of Basel, Basel, Switzerland 
l Christine Kühne-Center for Allergy Research and Education, Hochgebirgklinik Davos, Davos-Wolfgang, Switzerland 
n Department of Environmental Health, National Institute for Health and Welfare, Kuopio, Finland 
p Institute for Risk Assessment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands 

a LMU Munich, University Children's Hospital, Munich, Germany 
b University Hospital of Besançon and Plateforme de Biomonitoring, CIC-BT506, EFS Bourgogne Franche-Comté, INSERM UMR1098, University of Franche-Comté, Besançon, France 
c University Children's Hospital Eastern Bavaria (KUNO), Department of Pediatric Pneumology and Allergy, University of Regensburg, Regensburg, Germany 
d Laboratory for Epigenetics and Environment (LEE), Centre National de Genotypage, CEA-Institut de Genomique, Evry, France 
e Second Hospital of JI LIN University, Department of Respiratory Medicine, Chang Chun, China 
f Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany 
g Department of Clinical Chemistry and Molecular Diagnostics, Philipps University of Marburg, Marburg, Germany 
h Department of Environmental Science, University of Eastern Finland, Kuopio, Finland 
i Swiss Tropical and Public Health Institute, Basel, Switzerland 
j University of Basel, Basel, Switzerland 
k Children's Hospital Schwarzach, Schwarzach, Austria 
l Christine Kühne-Center for Allergy Research and Education, Hochgebirgklinik Davos, Davos-Wolfgang, Switzerland 
m University Hospital of Besançon, Research Unit Health and Rural Environment, University of Franche-Comté, Besançon, France 
n Department of Environmental Health, National Institute for Health and Welfare, Kuopio, Finland 
o Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland 

Corresponding author: Bianca Schaub, MD, LMU Munich, University Children's Hospital, Lindwurmstrasse 4, D 80337, Munich, Germany.

Abstract

Background

European cross-sectional studies have suggested that prenatal and postnatal farm exposure decreases the risk of allergic diseases in childhood. Underlying immunologic mechanisms are still not understood but might be modulated by immune-regulatory cells early in life, such as regulatory T (Treg) cells.

Objective

We sought to assess whether Treg cells from 4.5-year-old children from the Protection against Allergy: Study in Rural Environments birth cohort study are critical in the atopy and asthma-protective effect of farm exposure and which specific exposures might be relevant.

Methods

From 1133 children, 298 children were included in this study (149 farm and 149 reference children). Detailed questionnaires until 4 years of age assessed farming exposures over time. Treg cells were characterized as upper 20% CD4+CD25+ forkhead box protein 3 (FOXP3)+ (intracellular) in PBMCs before and after stimulation (with phorbol 12-myristate 13-acetate/ionomycin or LPS), and FOXP3 demethylation was assessed. Atopic sensitization was defined by specific IgE measurements; asthma was defined by a doctor's diagnosis.

Results

Treg cells were significantly increased in farm-exposed children after phorbol 12-myristate 13-acetate/ionomycin and LPS stimulation. Exposure to farm milk was defined as a relevant independent farm-related exposure supported by higher FOXP3 demethylation. Treg cell (upper 20% CD4+CD25+, FOXP3+ T cells) numbers were significantly negatively associated with doctor-diagnosed asthma (LPS stimulated: adjusted odds ratio, 0.26; 95% CI, 0.08-0.88) and perennial IgE (unstimulated: adjusted odds ratio, 0.21; 95% CI, 0.08-0.59). Protection against asthma by farm milk exposure was partially mediated by Treg cells.

Conclusions

Farm milk exposure was associated with increased Treg cell numbers on stimulation in 4.5-year-old children and might induce a regulatory phenotype early in life, potentially contributing to a protective effect for the development of childhood allergic diseases.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma, atopic sensitization, farming, FOXP3 demethylation, innate, milk, peripheral blood mononuclear cells, regulatory T cells

Abbreviations used : ALEX, EFRAIM, FITC, FOXP3, OR, PARSIFAL, PASTURE, PE, PI, SIC, TLR, Treg


Plan


 Supported by EFRAIM EU FP7- KBBE-2007-1, the Bavarian Research Association (to J.L.), SFB TR22 (to B.S. and A.L.), a Marie Curie Grant (MEST-CT-2005-020524-GALTRAIN; to A.L.), and the Comprehensive Pneumology Centre (to B.S.).
 Disclosure of potential conflict of interest: M. Depner has received research support from the European Research Council. J. Tost has received conference fees paid by Roche. M. Roponen has received research support from the European Union and the Academy of Finland. J. Weber has received research support from the European Commission. R. Lauener has received research support from the Kühne Foundation and European Union. D. A. Vuitton has received consulting fees from the URGO Foundation, France. J. Pekkanen has received research support from the European Union, Academy of Finland, and the Ministry of Social Affairs and Health. E. von Mutius has received consultancy fees from GlaxoSmithKline, ProtectImmun, Novartis, Astellas Pharma, Europe Ltd, and ALK-Abelló; has received lecture fees from InfectoPharma and Nestlé Research; has received research support from the European Commission; and has provided legal consultation/expert witness testimony for the UK Research Excellence Framework. B. Schaub has received research support from the DFG and the European Union. M. Ege has received grants from the European Commission and Deutsch Forschungsgemeinschaft and is an inventor for a patent regarding a pharmaceutical composition for protection from allergies and inflammatory disorders. M. Kabesch has received grants from the European Union, the German Ministry of Education and Research, and the German Research Foundation and has received payment for lectures from the European Respiratory Society, the European Academy of Allergology and Clinical Immunology, the American Thoracic Society, Novartis, and GlaxoSmithKline. G. Doekes has received research support from the European Commission and the Netherlands Asthma Fund. The rest of the authors declare that they have no relevant conflicts of interest.


© 2013  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 133 - N° 2

P. 551 - février 2014 Retour au numéro
Article précédent Article précédent
  • Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers
  • Gunda Herberth, Mario Bauer, Michaela Gasch, Denise Hinz, Stefan Röder, Sven Olek, Tibor Kohajda, Ulrike Rolle-Kampczyk, Martin von Bergen, Ulrich Sack, Michael Borte, Irina Lehmann, Lifestyle and Environmental Factors and Their Influence on Newborns Allergy Risk study group
| Article suivant Article suivant
  • Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration
  • Hesam Movassagh, Lianyu Shan, Andrew J. Halayko, Michael Roth, Michael Tamm, Jamila Chakir, Abdelilah S. Gounni

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.